Why the study?
Do medication nonadherence and therapy intensification impact systolic blood pressure control over time in patients with coronary disease?
Population
10,447 patients with coronary disease
Comparison
Medication nonadherence and therapy… vs Patients with high systolic blood pressure that…
Design
Cohort
Authors
Loading...
Nonadherence and intensification may flag persistent uncontrolled BP in CAD; hypothesis-generating for adherence trials before practice change.
Do medication nonadherence and therapy intensification impact systolic blood pressure control over time in patients with coronary disease?
Medication nonadherence significantly contributes to persistently elevated blood pressure in coronary disease patients despite therapy intensification.
Ho et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: